Common Stock, Shares, Outstanding of Jasper Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Jasper Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Jasper Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 27,984,039, a 87% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Jasper Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 27,984,039 +12,982,686 +87% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 16,219,243 +1,113,943 +7.4% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 15,022,122 -63,431 -0.42% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 15,022,122 +3,858,226 +35% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 15,001,353 -95,849,060 -86% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 15,105,300 -95,695,113 -86% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 15,085,553 -94,342,658 -86% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 11,163,896 +7,359,469 +193% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 110,850,413 +72,866,045 +192% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 110,800,413 +72,819,096 +192% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 109,428,211 +71,554,004 +189% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 3,804,427 -34,050,687 -90% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 37,984,368 +168,058 +0.44% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 37,981,317 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 37,874,207 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 37,855,114 +35,084,412 +1266% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 37,816,310 +37,080,097 +5037% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q4 2020 2,770,702 +2,078,929 +301% 31 Dec 2020 10-K 18 Mar 2022 2021 FY
Q3 2020 736,213 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q4 2019 691,773 31 Dec 2019 10-Q 10 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.